Skip to main content

Panic Disorder clinical trials at UCSF
1 in progress, 1 open to new patients

  • The Role of Orexin in Human Panic Disorder

    open to eligible people ages 18–65

    The purpose of this study is to provide some information (pilot data) about whether the study drug, suvorexant, (1) affects levels of orexin in people with panic disorder, and (2) is associated with decreased panic symptoms in response to a carbon dioxide (CO2) challenge.

    Fresno, California